Mylan introduces generic version of Vfend
Mylan Inc. has launched voriconazole tablets, an antifungal medication, under a previously announced settlement and license agreement with Pfizer Inc. The company said Tuesday that its Mylan Pharmaceuticals Inc. subsidiary introduced voriconazole tablets in strengths of 50 mg and 200 mg.